Admission Date:  [**2139-9-7**]              Discharge Date:   [**2139-9-10**]  Date of Birth:  [**2092-11-1**]             Sex:   F  Service: MEDICINE  Allergies: Epinephrine / Ciprofloxacin / Vicodin  Attending:[**First Name3 (LF) 2817**] Chief Complaint: diabetic ketoacidosis, hypertensive urgency  Major Surgical or Invasive Procedure: None  History of Present Illness: .
The patient is a 46 year old female with DM-1 x 35 years complicated by Diabetic Nephropathy, Neuropathy who was recently started on HD 1 month ago for ESRD [**2-27**] Diabetic Nephropathy.
The patient was recently admitted to [**Hospital1 18**] from [**2139-7-25**] to [**2139-8-8**] for treatment of pyelonephritis (Ucxs unrevealing) with initiation of HD during this hosptalization.
The patient reports she has not missed any doses of her insulin but has decreased her home BP meds given feeling lightheaed after HD sessions.
The patient was given 10U Regular insulin x 1 as well as 1L NS with improvement of AG to 12.
The patient was additionally treated for hypertensive urgency with SBP in 220s with Lopressor and Nitropaste.
Past Medical History: HTN DM1 last A1c 8.4 [**8-30**] c/b neuropathy and nephropathy CKD, stage2-3-- baseline creatinine 1.6-2.0-- secondary to DM, with signif microalbuminuria Anemia-- thought secondary to CKD baseline around 30, has had smear reviewed in [**2133**] with normocystic, normochromic anemia, nl SPEP [**5-/2137**], negative work up in [**5-/2132**] Hypothyroidism hyperlipidemia axonal peripheral neuropathy with some demyelinating features anxiety Hx of myeloid sarcoma with skin biopsy chronic eosinophilia   Social History: 1 yr tobacco use 25yrs ago, no etoh or other drugs.
UA/Urine Cultures: [**2138-9-9**] - mixed bacterial flora (>=3 colony types, consistent with skin and /or genital contamination.)
Interval placement of right IJ dialysis catheter, no pneumothorax.
Given this, the patient is now transferred to ICU for ongoing management of DKA.
Patient reports medications compliance.
Zofran and reglan were given PRN nausea.
DKA resolved with insulin drip, and anion gap closed within 24 hours of ICU admission.
Pt was able to transition back to usual subcutaneous insulin once she was able to take po nutrition with resolution of nausea and vomiting.
Labile blood glucose overnight after insulin drip stopped but thought to be secondary to altered PO diet; also glucose at home levels are somewhat labile as an outpatient.
On the morning of discharge, the patient received glargine 10 units as [**First Name8 (NamePattern2) **] [**Last Name (un) **] consult recommendatins and continued sliding scale insulin ACHS.
The patient was instructed to resume home insulin regimen and also to follow-up with her endocrinologist.
Hypertensin controlled in ICU on outpatient regimen.
Continue outpatient BP regimen.
Patient due for HD T/R/S.
Patient had HD beside in ICU; final HD was on morning of discharge home.
Resume T/R/S schedule as per outpatient regimen.
Continue Cinacalcet, Nephrocaps.
Continued Lexapro in ICU and patient to continue Lexapro as an outpatient.
Hypothyroidism - Levothyroxine continued as an inpatient.
Access: PIV to be dc'ed at discharge, Tunneled HD catheter .
Escitalopram 10 mg po daily 2.
Amlodipine 10 mg po daily 3.
Levothyroxine 75 mcg po daily 4.
Zetia 10 mg po daily 5.
Ferrous Sulfate 325 mg [**Hospital1 **] 6.
Labetalol 100 mg PO qHS, 50mg Qam 7.
Clonidine 0.1 mg Tablet PO BID 9.
B Complex-Vitamin C-Folic Acid 1 mg daily 10.
Cinacalcet 30 mg po daily 11.
Insulin Glargine 8 units QHS, HSS with carb counting during day .
Allergies: Cipro - Swelling Vicodin - Hallucinations Contrast Dye - Renal failure .
Escitalopram 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Amlodipine 5 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).
Levothyroxine 75 mcg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Ezetimibe 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Ferrous Sulfate 325 (65) mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Labetalol 100 mg Tablet Sig: One (1) Tablet PO QPM (once a day (in the evening)).
Labetalol 100 mg Tablet Sig: 0.5 Tablet PO QAM (once a day (in the morning)).
Clonidine 0.1 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Cinacalcet 30 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Nephrocaps 1 mg Capsule Oral 11.
Insulin Glargine 100 unit/mL Solution Sig: One (1) 7 Subcutaneous at bedtime.
Insulin NPH Human Recomb 100 unit/mL Suspension Sig: One (1) 2 Subcutaneous q AM.
You were in diabetic ketoacidosis which resolved with an insulin drip within 24 hours of ICU admission.
You were transitioned back to usual subcutaneous insulin once you were able to take nutrition by mouth.
Please follow-up with Dr. [**First Name (STitle) **] for hemodialysis at [**Hospital1 **] [**Location (un) 1121**] and resume outpatient Tuesday/Thursday/Saturday schedule.
